Compare Dishman Pharma with Orchid Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DISHMAN PHARMA vs ORCHID PHARMA - Comparison Results

DISHMAN PHARMA     Change

Dishman Pharmaceuticals is involved in the manufacture of APIs (active pharmaceutical ingredients), intermediates, quaternary compounds and fine chemicals. Besides this, the company is a significant player in the CRAMS (Contract Research and Manufact... More

ORCHID PHARMA 
   Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DISHMAN PHARMA ORCHID PHARMA DISHMAN PHARMA/
ORCHID PHARMA
 
P/E (TTM) x 25.1 -26.0 - View Chart
P/BV x 3.3 7.4 45.0% View Chart
Dividend Yield % 0.7 0.0 -  

Financials

 DISHMAN PHARMA   ORCHID PHARMA
EQUITY SHARE DATA
    DISHMAN PHARMA
Mar-16
ORCHID PHARMA
Sep-13
DISHMAN PHARMA/
ORCHID PHARMA
5-Yr Chart
Click to enlarge
High Rs374194 193.0%   
Low Rs12935 368.3%   
Sales per share (Unadj.) Rs197.8276.5 71.5%  
Earnings per share (Unadj.) Rs21.2-79.2 -26.8%  
Cash flow per share (Unadj.) Rs34.7-43.5 -79.9%  
Dividends per share (Unadj.) Rs2.000-  
Dividend yield (eoy) %0.80-  
Book value per share (Unadj.) Rs179.953.9 333.5%  
Shares outstanding (eoy) m80.6970.45 114.5%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x1.30.4 307.2%   
Avg P/E ratio x11.9-1.4 -820.9%  
P/CF ratio (eoy) x7.2-2.6 -275.0%  
Price / Book Value ratio x1.42.1 65.9%  
Dividend payout %9.40-   
Avg Mkt Cap Rs m20,3068,067 251.7%   
No. of employees `0000.82.8 29.6%   
Total wages/salary Rs m5,3552,527 211.9%   
Avg. sales/employee Rs Th19,252.76,956.1 276.8%   
Avg. wages/employee Rs Th6,459.5902.5 715.7%   
Avg. net profit/employee Rs Th2,064.1-1,993.0 -103.6%   
INCOME DATA
Net Sales Rs m15,96119,477 81.9%  
Other income Rs m265407 65.2%   
Total revenues Rs m16,22619,884 81.6%   
Gross profit Rs m4,1031,103 372.1%  
Depreciation Rs m1,0912,519 43.3%   
Interest Rs m9445,227 18.1%   
Profit before tax Rs m2,334-6,236 -37.4%   
Minority Interest Rs m020 0.0%   
Prior Period Items Rs m10-   
Extraordinary Inc (Exp) Rs m0511 0.0%   
Tax Rs m624-125 -498.1%   
Profit after tax Rs m1,711-5,580 -30.7%  
Gross profit margin %25.75.7 454.1%  
Effective tax rate %26.72.0 1,331.1%   
Net profit margin %10.7-28.7 -37.4%  
BALANCE SHEET DATA
Current assets Rs m11,01811,014 100.0%   
Current liabilities Rs m9,51732,060 29.7%   
Net working cap to sales %9.4-108.1 -8.7%  
Current ratio x1.20.3 337.0%  
Inventory Days Days11095 116.5%  
Debtors Days Days3534 103.8%  
Net fixed assets Rs m16,30429,440 55.4%   
Share capital Rs m161705 22.9%   
"Free" reserves Rs m12,9072,043 631.9%   
Net worth Rs m14,5163,800 382.0%   
Long term debt Rs m4,1899,018 46.5%   
Total assets Rs m29,80546,510 64.1%  
Interest coverage x3.5-0.2 -1,797.3%   
Debt to equity ratio x0.32.4 12.2%  
Sales to assets ratio x0.50.4 127.9%   
Return on assets %8.9-0.8 -1,172.2%  
Return on equity %11.8-146.9 -8.0%  
Return on capital %17.5-3.7 -469.4%  
Exports to sales %24.837.9 65.4%   
Imports to sales %3.722.6 16.5%   
Exports (fob) Rs m3,9567,378 53.6%   
Imports (cif) Rs m5964,406 13.5%   
Fx inflow Rs m4,9527,513 65.9%   
Fx outflow Rs m6975,649 12.3%   
Net fx Rs m4,2551,865 228.2%   
CASH FLOW
From Operations Rs m2,7861,682 165.7%  
From Investments Rs m-1,529-9,860 15.5%  
From Financial Activity Rs m-9416,644 -14.2%  
Net Cashflow Rs m316-1,535 -20.6%  

Share Holding

Indian Promoters % 61.4 32.3 190.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.7 4.6 80.4%  
FIIs % 12.7 3.3 384.8%  
ADR/GDR % 0.0 4.6 -  
Free float % 22.1 55.3 40.0%  
Shareholders   46,261 84,811 54.5%  
Pledged promoter(s) holding % 35.8 54.9 65.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DISHMAN PHARMA With:   NEULAND LABS  DR. REDDYS LAB  GSK PHARMA  UNICHEM LAB  WYETH  

Compare DISHMAN PHARMA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

5 Reasons Why Sensex Plunged 536 Points Today(Closing)

Extending losses to the fifth straight session, Indian share markets witnessed selling pressure throughout the day today and ended deep in the red.

Related Views on News

ORCHID PHARMA LTD Announces Quarterly Results (2QFY19); Net Profit Up 67.1% (Quarterly Result Update)

Jan 31, 2019 | Updated on Jan 31, 2019

For the quarter ended September 2018, ORCHID PHARMA LTD has posted a net profit of Rs 231 m (up 67.1% YoY). Sales on the other hand came in at Rs 1 bn (down 31.9% YoY). Read on for a complete analysis of ORCHID PHARMA LTD's quarterly results.

ORCHID PHARMA LTD Announces Quarterly Results (2QFY19); Net Profit Up 67.1% (Quarterly Result Update)

Jan 31, 2019 | Updated on Jan 31, 2019

For the quarter ended September 2018, ORCHID PHARMA LTD has posted a net profit of Rs 231 m (up 67.1% YoY). Sales on the other hand came in at Rs 1 bn (down 31.9% YoY). Read on for a complete analysis of ORCHID PHARMA LTD's quarterly results.

More Views on News

Most Popular

Time to Book Profits in Pharma Stocks(Fast Profits Daily)

Jan 15, 2021

In this video, I'll show you why it might be the right time to take money of the table in pharma stocks.

Smallcap Stocks: Your Best Bet for 2021 and Beyond(Profit Hunter)

Jan 15, 2021

The pandemic failed to thwart Richa's investing success formula for 2020.

One Chart to See Before You Sell(Fast Profits Daily)

Jan 22, 2021

In this video, I'll show you a crucial chart that you need to check before you decide to sell any stock or index.

Invest in the Multibaggers of 2021 and Beyond(Profit Hunter)

Jan 21, 2021

Our ace stock picker is ready to capitalise on a big growth opportunity.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

DISHMAN PHARMA SHARE PRICE


May 29, 2017 (Close)

TRACK DISHMAN PHARMA

  • Track your investment in DISHMAN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DISHMAN PHARMA

DISHMAN PHARMA 5-YR ANALYSIS

COMPARE DISHMAN PHARMA WITH

MARKET STATS